-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Immune tolerance induction in hemophilia
Maria Elisa Mancuso & Antonino Cannavo
Clinical Trail Outcomes: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation